📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Celltrion Inc

Common Name

Celltrion

Country

South Korea

Sector

Healthcare

Industry

Biotechnology

Employees

2,680

Ticker

068270

Exchange

KOREA EXCHANGE

Website

www.celltrion.com

Description

Celltrion Inc. is one of the world's formidable players in the biopharmaceutical industry, focusing on the development, manufacture, and commercialization of innovative therapies. Known for its monocl... Show more

Income Statement Balance Sheet Group Entities

Celltrion's Financial Statements Preview

Below are the financial statements of Celltrion, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of KRW	2024 as of 2024-12-31	2023 as of 2023-12-31	2022 as of 2022-12-31
Assets	—	—	—
Current assets	5,584.13^a	5,094.01^a	2,929.79^a
Cash and cash equivalents	996.43^a	564.61^a	551.19^a
Short-term financial assets	146.65^a	193.82^a	43.28^a
Trade receivables	1,215.25^a	939.17^a	1,621.89^a
Other receivables	45.23^a	10.18^a	32.2^a
Inventories	2,765.94^a	3,038.71^a	616.35^a
Current tax assets	12.23^a	5.1^a	0^a
Other current assets	402.39^a	213.95^a	64.89^a
Non-current assets held for sale	0^a	128.47^a	0^a
Non-current assets	15,471.09^a	14,862.8^a	2,961.86^a
Long-term financial assets	49.11^a	30.39^a	29.27^a
Long-term trade receivables	0^a	0^a	62.89^a
Long-term other receivables	106.9^a	91.49^a	91.15^a
Investments in associates and joint ventures	111.68^a	104.71^a	88.54^a
Property, plant and equipment	1,244.57^a	1,214.59^a	1,007.04^a
Intangible assets, net	13,701.62^a	13,290.74^a	1,622.33^a
Investment property	0.27^a	0.28^a	0^a
Other non-current assets	62.66^a	67.14^a	28.46^a
Deferred tax assets	194.28^a	63.47^a	32.18^a
Total assets	21,055.22^a	19,956.81^a	5,891.65^a
Liabilities	—	—	—
Current liabilities	3,187.12^a	2,512.39^a	1,294.1^a
Short-term financial liabilities	2,102.34^a	1,783.37^a	665.01^a
Trade payables	75.31^a	50.85^a	50.27^a
Other payables	474.86^a	435.76^a	320.24^a
Current tax liabilities	218.48^a	57.04^a	88.7^a
Provisions	2.03^a	1.86^a	1.49^a
Other current liabilities	314.1^a	183.5^a	168.38^a
Non-current liabilities	288.04^a	318.63^a	323.35^a
Long-term financial liabilities	105.68^a	107.12^a	154.47^a
Long-term other payables	9.32^a	5.87^a	7.58^a
Other non-current liabilities	73.77^a	88.63^a	160.2^a
Deferred tax liabilities	99.26^a	117.02^a	1.11^a
Total liabilities	3,475.16^a	2,831.02^a	1,617.45^a

Verified Sources Behind Celltrion’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Celltrion’s data sources below and access millions more through our Disclosure Search.

a. Celltrion's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Celltrion Inc

Celltrion's Financial Statements Preview

Celltrion's Financial Statements Preview

Verified Sources Behind Celltrion’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Alteogen Inc

BeOne Medicines AG

Royalty Pharma PLC

Moderna Inc

Bio-Techne Corp

Halozyme Therapeutics Inc